EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients ...

St. Luke’s Medical Center (SLMC) has opened an inhaler clinic service specifically designed to cater to patients with ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

In an analysis adjusted for tobacco cigarette use, the likelihood for asthma and COPD significantly rose with daily cannabis ...

ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients Glasmacinal, a novel macrolide, was well tolerated and reduced neutrophilic inflammation in COPD patients ...

A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care ...

Hospitalizations for bronchiectasis exacerbations are associated with poorer in-hospital outcomes than those for chronic obstructive pulmonary disease or asthma exacerbations.

In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...

A mum-of-five who has lived with asthma since she was four months old and now battles COPD faces insults from strangers in ...

Fiscal policy tightened on harmful products, with higher excise and a proposed health cess on tobacco and pan masala framed ...

Non-cystic fibrosis bronchiectasis (NCFB) is a heterogeneous disease characterised by a ‘vicious vortex’ of ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 8, 2025 (HealthDay News) — Discharging hospital patients early to recover ...